Selected article for: "cell line and conformational change"
Author: Zhao, Yu; Guo, Na; Lou, Li-Guang; Cong, Yu-Wen; Peng, Li-Yan; Zhao, Qin-Shi
Title: Synthesis, cytotoxic activity, and SAR analysis of the derivatives of taxchinin A and brevifoliol
  • Cord-id: ur868lpg
  • Document date: 2008_5_1
    • ID: ur868lpg
    Snippet: Twenty-one derivatives of taxchinin A (1) and brevifoliol (2) were synthesized and evaluated for cytotoxicity against human non-small lung cancer (A549) cell line. Nine derivatives showed potent activity with IC(50) values from 0.48 to 6.22 μM. 5-Oxo-13-TBDMS-taxchinin A (11) and 5-oxo-13,15-epoxy-13-epi-taxchinin A (15) are the most potent derivatives, with IC(50) at 0.48 and 0.75 μM, respectively. The structure–activity relationship (SAR) of these compounds established that exocyclic unsat
    Document: Twenty-one derivatives of taxchinin A (1) and brevifoliol (2) were synthesized and evaluated for cytotoxicity against human non-small lung cancer (A549) cell line. Nine derivatives showed potent activity with IC(50) values from 0.48 to 6.22 μM. 5-Oxo-13-TBDMS-taxchinin A (11) and 5-oxo-13,15-epoxy-13-epi-taxchinin A (15) are the most potent derivatives, with IC(50) at 0.48 and 0.75 μM, respectively. The structure–activity relationship (SAR) of these compounds established that exocyclic unsaturated ketone at ring C is the key structural element for the activity, while the α,β-unsaturated ketone positioned at ring A has no effect for the activity. The significant cytotoxicity of derivatives 11 and 15 may be due to the conformational change in the taxane rings. The 3D-QSAR study was conducted on this series of compounds, which provided optimal predictive comparative molecular field (CoMFA) model with cross-validated r(2) (q(2)) value of 0.64.

    Search related documents:
    Co phrase search for related documents
    • action novel mechanism and acute respiratory syndrome: 1, 2
    • action novel mechanism and lung cancer: 1, 2
    • activity decrease and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • activity decrease and lung cancer: 1, 2, 3, 4
    • activity decrease increase and acute respiratory syndrome: 1, 2, 3, 4
    • activity decrease increase and lung cancer: 1
    • activity effect and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity effect and lung cancer: 1, 2, 3, 4, 5
    • activity exhibit and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity exhibit and lung cancer: 1
    • activity favorable and acute respiratory syndrome: 1, 2
    • activity favorable and lung cancer: 1
    • activity find and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • activity show and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity show and lung cancer: 1, 2, 3, 4, 5